Article
The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status.
Cancer reports (Hoboken, N.J.) - 1 Sept 2022
Shao Jun, Li Jingwei, Song Lujia, He Qiuyao, Wu Yuxuan, Li Linhui, Liu Dan, Wang Chengdi, Li Weimin
Abstract excerpt
BACKGROUND: Lung cancer is the common cause of cancer-related deaths throughout the world, and brain is a frequent metastatic site of lung cancer. AIM: This research sought to evaluate the impact of the number of brain metastases in prognosticating non-small cell lung cancer (NSCLC) patients accounting to the role of epidermal growth factor receptor (EGFR) mutations. METHODS AND RESULTS: NSCLC patients with brain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
